tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

CLNN Stock Latest News

Clene price target lowered to $31 from $33 at Benchmark
The FlyClene price target lowered to $31 from $33 at Benchmark
10d ago
CLNN
Clene Expands Equity Distribution to Raise Capital
PremiumCompany Announcements
Clene Expands Equity Distribution to Raise Capital
14d ago
8K
CLNN
Clene files to sell 491,496 shares of common stock for holders
PremiumThe Fly
Clene files to sell 491,496 shares of common stock for holders
14d ago
CLNN
Clene’s CNM-Au8 Shows Promise in Parkinson’s Treatment, Justifying Buy Rating
PremiumRatings
Clene’s CNM-Au8 Shows Promise in Parkinson’s Treatment, Justifying Buy Rating
15d ago
CLNN
Clene presents preclinical data supporting CNM-Au8 for Parkinson’s disease
PremiumThe Fly
Clene presents preclinical data supporting CNM-Au8 for Parkinson’s disease
16d ago
CLNN
Clene presents preclinical data supporting CNM-Au8 for Parkinson’s disease
PremiumThe FlyClene presents preclinical data supporting CNM-Au8 for Parkinson’s disease
16d ago
CLNN
Clene price target lowered to $48 from $83 at Canaccord
Premium
The Fly
Clene price target lowered to $48 from $83 at Canaccord
1M ago
CLNN
Clene Inc. Reports Q2 2025 Financial Results
Premium
Company Announcements
Clene Inc. Reports Q2 2025 Financial Results
1M ago
CLNN
Optimistic Buy Rating for Clene Amidst Regulatory Progress and Strategic Milestones in ALS Treatment
PremiumRatings
Optimistic Buy Rating for Clene Amidst Regulatory Progress and Strategic Milestones in ALS Treatment
1M ago
CLNN
Clene Amends Notes and Secures New Financing
PremiumCompany Announcements
Clene Amends Notes and Secures New Financing
1M ago
8K
CLNN
Clene reports Q2 EPS (78c) vs ($1.06) last year
PremiumThe Fly
Clene reports Q2 EPS (78c) vs ($1.06) last year
1M ago
CLNN
Clene Files Prospectus for Additional Share Offering
PremiumCompany Announcements
Clene Files Prospectus for Additional Share Offering
3M ago
8K
CLNN
Clene Announces Regulatory Update After FDA Meeting
PremiumCompany AnnouncementsClene Announces Regulatory Update After FDA Meeting
3M ago
8K
CLNN
Clene provides regulatory update following FDA Type C meeting
Premium
The Fly
Clene provides regulatory update following FDA Type C meeting
3M ago
CLNN
Clene Regains Nasdaq Compliance as of June 2025
Premium
Company Announcements
Clene Regains Nasdaq Compliance as of June 2025
3M ago
8K
CLNN
Clene management to meet with Maxim
PremiumThe Fly
Clene management to meet with Maxim
4M ago
CLNN
Clene Approves Stock Plan Amendment at Annual Meeting
PremiumCompany Announcements
Clene Approves Stock Plan Amendment at Annual Meeting
4M ago
8K
CLNN
Clene Inc. Reports Reduced Losses Amid Strategic Cost-Saving Measures
PremiumCompany Announcements
Clene Inc. Reports Reduced Losses Amid Strategic Cost-Saving Measures
4M ago
CLNN
Clene’s Strategic Financial Management and Promising Clinical Developments Drive Buy Rating
PremiumRatings
Clene’s Strategic Financial Management and Promising Clinical Developments Drive Buy Rating
4M ago
CLNN
Clene’s Strategic Focus and Promising CNM-Au8 Developments Drive Buy Rating
PremiumRatingsClene’s Strategic Focus and Promising CNM-Au8 Developments Drive Buy Rating
5M ago
CLNN
Clene Faces Nasdaq Delisting Risk Amid Regulatory Pursuits
Premium
Company Announcements
Clene Faces Nasdaq Delisting Risk Amid Regulatory Pursuits
5M ago
8K
CLNN
Clene reports Q1 EPS (9c), consensus (78c)
Premium
The Fly
Clene reports Q1 EPS (9c), consensus (78c)
5M ago
CLNN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >